Sequencing new agents after docetaxel in patients with metastatic castration-resistant prostate cancer.

Critical Reviews in Oncology/hematology
Francesca MainesEmilio Bria

Abstract

Two new hormonal agents (NHAs), abiraterone and enzalutamide, and one chemotherapeutic agent, cabazitaxel (CABA) improved overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) who progress after docetaxel. Although several analyses of patient cohorts receiving a sequence of two different new agents (NAs) after docetaxel have been published, no definite conclusions can be drawn regarding the best treatment strategy. All published studies reporting monthly OS rates of mCRPC patients receiving third-line NA after having previously received docetaxel and another NA have been analyzed. The treatments were merged into three groups: one NHA followed by another, one NHA followed by CABA, and CABA followed by one NHA. The cumulative monthly OS rates in each group were determined using a weighted-average approach. Thirteen retrospective studies including 1016 patients who received NHA/NHA (469), NHA/CABA (318) or CABA/NHA (229) were evaluated. The 12-month OS rates were 28.5%, 61.3%, and 76.4%, respectively. There were no statistically significant differences in terms of known prognostic factors. Although the retrospective nature of the studies and potential selection biases, our data seem to conf...Continue Reading

References

Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J Vogelzang
Nov 15, 2011·The Journal of Urology·Patrick C Walsh
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Apr 12, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y LoriotC Massard
Apr 16, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K L NoonanK N Chi
Oct 1, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D BianchiniJ S de Bono
Nov 10, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J van SoestW M van Weerden
Jan 21, 2014·Advances in Therapy·Sebastian Christoph SchmidMargitta Retz
Jan 28, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David ThomsonOmi Parikh
Feb 22, 2014·Cancer Research·Maria Thadani-MuleroParaskevi Giannakakou
May 27, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Ryan W DobbsDaniel J Canter
Jun 3, 2014·The New England Journal of Medicine·Tomasz M BeerUNKNOWN PREVAIL Investigators
Oct 30, 2014·The New England Journal of Medicine·Tomasz M Beer, Bertrand Tombal

❮ Previous
Next ❯

Citations

Feb 10, 2016·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J CassinelloL Antón Aparicio
Dec 22, 2017·International Journal of Urology : Official Journal of the Japanese Urological Association·Kazumasa KomuraPhilip W Kantoff
Jan 5, 2018·Prostate Cancer and Prostatic Diseases·Chris ParkerNeal Shore
Oct 1, 2019·The New England Journal of Medicine·Ronald de WitUNKNOWN CARD Investigators
Nov 30, 2019·Der Urologe. Ausg. A·P AlbersM De Santis
Aug 20, 2019·Future Oncology·Orazio CaffoCarlo Messina
Dec 17, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Finn Edler von EybenTimo Joensuu
Nov 28, 2020·Expert Review of Anticancer Therapy·Orazio CaffoCarlo Messina
Aug 28, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Özgecan DülgarMahmut Gümüş
Mar 7, 2021·Diagnostics·Ciara S McNevinStephen P Finn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.